Merck To Get $600M For Eye-Care Biz in Japan, Europe
Merck & Co. will sell its ophthalmology assets in Japan and other key markets in Europe and the Asia-Pacific to Japanese drugmaker Santen Pharmaceutical Co. Ltd. for $600 million upfront and...To view the full article, register now.
Already a subscriber? Click here to view full article